Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Clinical trial NCT00334815 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT00334815
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Adenocarcinoma Lung Adenosquamous Carcinoma Lung Large Cell Carcinoma Lung Squamous Cell Carcinoma Minimally Invasive Lung Adenocarcinoma Stage IIIA Lung Non-Small Cell Cancer AJCC v7 Stage IIIB Lung Non-Small Cell Cancer AJCC v7

Start date: 2006-06-15
Primary completion: 2014-07-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.